With new beginnings comes new hope.  As we enter 2021, screening will begin for the our Phase 1/2 RESKUE trial – the first in-human gene therapy clinical trial for patients with Krabbe Disease.  Learn more about the RESKUE trial here: https://clinicaltrials.gov/ct2/show/NCT04693598?term=NCT04693598